List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume for the Year 2017-2028
1.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume for the Year 2017-2028
1.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Gastrointestinal Stromal Tumor (GIST) Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Gastrointestinal Stromal Tumor (GIST) Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics
1.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
1.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
1.5.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
1.5.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Type
2.1.1 Amcasertib
2.1.2 Anagrelide hydrochloride CR
2.1.3 APG-1351
2.1.4 Binimetinib
2.1.5 Others
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
2.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
2.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
3.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Gastrointestinal Stromal Tumor (GIST) Drug Competitor Landscape by Company
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Company
4.1.1 Top Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturer (2017-2022)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Concentration Ratio (CR)
4.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug in 2021
4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
4.3.3 Date of International Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Company
4.5.1 Top Gastrointestinal Stromal Tumor (GIST) Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Players (2020, 2021 & 2022)
5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region: 2017-2022
5.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
7.1.2 Ariad Pharmaceuticals, Inc. Description and Business Overview
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.1.5 Ariad Pharmaceuticals, Inc. Recent Development
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Arog Pharmaceuticals, Inc. Corporation Information
7.2.2 Arog Pharmaceuticals, Inc. Description and Business Overview
7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.2.5 Arog Pharmaceuticals, Inc. Recent Development
7.3 Array BioPharma Inc.
7.3.1 Array BioPharma Inc. Corporation Information
7.3.2 Array BioPharma Inc. Description and Business Overview
7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.3.5 Array BioPharma Inc. Recent Development
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Astex Pharmaceuticals, Inc. Corporation Information
7.4.2 Astex Pharmaceuticals, Inc. Description and Business Overview
7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.4.5 Astex Pharmaceuticals, Inc. Recent Development
7.5 Blueprint Medicines Corporation
7.5.1 Blueprint Medicines Corporation Corporation Information
7.5.2 Blueprint Medicines Corporation Description and Business Overview
7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.5.5 Blueprint Medicines Corporation Recent Development
7.6 Boston Biomedical, Inc.
7.6.1 Boston Biomedical, Inc. Corporation Information
7.6.2 Boston Biomedical, Inc. Description and Business Overview
7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.6.5 Boston Biomedical, Inc. Recent Development
7.7 Calithera Biosciences, Inc.
7.7.1 Calithera Biosciences, Inc. Corporation Information
7.7.2 Calithera Biosciences, Inc. Description and Business Overview
7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.7.5 Calithera Biosciences, Inc. Recent Development
7.8 Chipscreen Biosciences Ltd
7.8.1 Chipscreen Biosciences Ltd Corporation Information
7.8.2 Chipscreen Biosciences Ltd Description and Business Overview
7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.8.5 Chipscreen Biosciences Ltd Recent Development
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Deciphera Pharmaceuticals, LLC Corporation Information
7.9.2 Deciphera Pharmaceuticals, LLC Description and Business Overview
7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.9.5 Deciphera Pharmaceuticals, LLC Recent Development
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
7.10.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.10.5 F. Hoffmann-La Roche Ltd. Recent Development
7.11 Horizon Pharma Plc
7.11.1 Horizon Pharma Plc Corporation Information
7.11.2 Horizon Pharma Plc Description and Business Overview
7.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.11.5 Horizon Pharma Plc Recent Development
7.12 Immunicum AB
7.12.1 Immunicum AB Corporation Information
7.12.2 Immunicum AB Description and Business Overview
7.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Immunicum AB Products Offered
7.12.5 Immunicum AB Recent Development
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
7.13.2 Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
7.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Jiangsu Hengrui Medicine Co., Ltd. Products Offered
7.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development
7.14 Kolltan Pharmaceuticals, Inc.
7.14.1 Kolltan Pharmaceuticals, Inc. Corporation Information
7.14.2 Kolltan Pharmaceuticals, Inc. Description and Business Overview
7.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Kolltan Pharmaceuticals, Inc. Products Offered
7.14.5 Kolltan Pharmaceuticals, Inc. Recent Development
7.15 Natco Pharma Limited
7.15.1 Natco Pharma Limited Corporation Information
7.15.2 Natco Pharma Limited Description and Business Overview
7.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Natco Pharma Limited Products Offered
7.15.5 Natco Pharma Limited Recent Development
7.16 Nerviano Medical Sciences S.r.l.
7.16.1 Nerviano Medical Sciences S.r.l. Corporation Information
7.16.2 Nerviano Medical Sciences S.r.l. Description and Business Overview
7.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Nerviano Medical Sciences S.r.l. Products Offered
7.16.5 Nerviano Medical Sciences S.r.l. Recent Development
7.17 Novartis AG
7.17.1 Novartis AG Corporation Information
7.17.2 Novartis AG Description and Business Overview
7.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Novartis AG Products Offered
7.17.5 Novartis AG Recent Development
7.18 Omeros Corporation
7.18.1 Omeros Corporation Corporation Information
7.18.2 Omeros Corporation Description and Business Overview
7.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Omeros Corporation Products Offered
7.18.5 Omeros Corporation Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis
8.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
8.3 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process
8.4 Gastrointestinal Stromal Tumor (GIST) Drug Sales and Marketing
8.4.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels
8.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
8.5 Gastrointestinal Stromal Tumor (GIST) Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
